Filter News
Area of Research
- (-) Clean Energy (43)
- (-) Materials (57)
- (-) Neutron Science (46)
- Advanced Manufacturing (3)
- Biology and Environment (17)
- Computational Engineering (1)
- Computer Science (3)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (13)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (2)
- Materials Characterization (1)
- Materials for Computing (7)
- Materials Under Extremes (1)
- National Security (14)
- Nuclear Science and Technology (8)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (43)
News Type
News Topics
- (-) Composites (6)
- (-) Computer Science (15)
- (-) Grid (10)
- (-) Machine Learning (5)
- (-) Materials Science (43)
- (-) Neutron Science (42)
- (-) Nuclear Energy (5)
- (-) Security (4)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (34)
- Advanced Reactors (3)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (17)
- Biology (10)
- Biomedical (8)
- Biotechnology (3)
- Buildings (8)
- Chemical Sciences (20)
- Clean Water (1)
- Climate Change (8)
- Coronavirus (9)
- Critical Materials (10)
- Cybersecurity (5)
- Decarbonization (11)
- Energy Storage (36)
- Environment (18)
- Exascale Computing (2)
- Fossil Energy (1)
- Frontier (3)
- Fusion (3)
- High-Performance Computing (5)
- Isotopes (5)
- ITER (1)
- Materials (46)
- Mercury (1)
- Microscopy (12)
- Molten Salt (2)
- Nanotechnology (23)
- National Security (5)
- Net Zero (1)
- Partnerships (11)
- Physics (16)
- Polymers (9)
- Quantum Computing (1)
- Quantum Science (11)
- Renewable Energy (1)
- Simulation (1)
- Summit (5)
- Sustainable Energy (25)
- Transformational Challenge Reactor (3)
- Transportation (19)
Media Contacts
Four scientists affiliated with ORNL were named Battelle Distinguished Inventors during the lab’s annual Innovation Awards on Dec. 1 in recognition of being granted 14 or more United States patents.
Guided by machine learning, chemists at ORNL designed a record-setting carbonaceous supercapacitor material that stores four times more energy than the best commercial material.
Researchers at ORNL have been leading a project to understand how a high-altitude electromagnetic pulse, or EMP, could threaten power plants.
In a finding that helps elucidate how molten salts in advanced nuclear reactors might behave, scientists have shown how electrons interacting with the ions of the molten salt can form three states with different properties. Understanding these states can help predict the impact of radiation on the performance of salt-fueled reactors.
Using neutrons to see the additive manufacturing process at the atomic level, scientists have shown that they can measure strain in a material as it evolves and track how atoms move in response to stress.
ORNL has been selected to lead an Energy Earthshot Research Center, or EERC, focused on developing chemical processes that use sustainable methods instead of burning fossil fuels to radically reduce industrial greenhouse gas emissions to stem climate change and limit the crisis of a rapidly warming planet.
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
Quantum computers process information using quantum bits, or qubits, based on fragile, short-lived quantum mechanical states. To make qubits robust and tailor them for applications, researchers from the Department of Energy’s Oak Ridge National Laboratory sought to create a new material system.
A licensing agreement between the Department of Energy’s Oak Ridge National Laboratory and research partner ZEISS will enable industrial X-ray computed tomography, or CT, to perform rapid evaluations of 3D-printed components using ORNL’s machine
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.